You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vitritis

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular Diagnostic for VitreoRetinal Lymphoma

Not yet recruiting
  • Vitreoretinal Lymphoma
    • (no location specified)
    Apr 21, 2023

    Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion Trial in Palo Alto (Episcleral Dexamethasone)

    Unknown status
    • Macular Edema
    • +6 more
    • Episcleral Dexamethasone
    • Palo Alto, California
      Stanford Medicine Ophthalmology
    Oct 7, 2019

    Advanced Retinitis Pigmentosa Trial in United States (RST-001)

    Active, not recruiting
    Has Results
    • Advanced Retinitis Pigmentosa
    • San Francisco, California
    • +3 more
    Sep 9, 2022

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Oct 19, 2021

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    X-linked Retinoschisis Trial in United States (rAAV2tYF-CB-hRS1)

    Active, not recruiting
    Has Results
    • X-linked Retinoschisis
    • rAAV2tYF-CB-hRS1
    • San Francisco, California
    • +8 more
    Jul 18, 2022

    Cataract Trial in Irvine (T-Pred, Pred Forte)

    Completed
    Has Results
    • Cataract
    • Irvine, California
      ISTA Pharmaceuticals, Inc.
    Oct 16, 2020

    Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)

    Terminated
    Has Results
    • Branch Retinal Vein Occlusion
    • Brolucizumab 6 mg
    • +2 more
    • Phoenix, Arizona
    • +101 more
    Jan 27, 2023

    Corneal Blindness, Boston Keratoprosthesis Type I Candidate Trial in Montréal (Boston KPro type I - fresh graft, Boston KPro

    Completed
    • Corneal Blindness
    • Boston Keratoprosthesis Type I Candidate
    • Boston KPro type I - fresh graft
    • Boston KPro type I surgery - frozen graft
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Jan 26, 2021

    Tolerability of Sub-retinal Transplantation of Human Embryonic

    Completed
    • Stargardt's Macular Dystrophy
    • hESC-RPE
    • London, United Kingdom
    • +1 more
    Dec 9, 2020

    Sub-retinal Transplantation of hESC Derived RPE Cells in

    Completed
    • Stargardt's Macular Dystrophy
    • MA09-hRPE
    • Los Angeles, California
    • +2 more
    Nov 10, 2020

    Sub-retinal Transplantation of hESC Derived RPE Cells in AMD

    Completed
    • Age-Related Macular Degeneration
    • MA09-hRPE
    • Los Angeles, California
    • +3 more
    Nov 10, 2020

    Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)

    Completed
    Has Results
    • Non-Infectious Uveitis
    • FAI insert
    • Sham injection
    • Beverly Hills, California
    • +33 more
    Mar 5, 2021

    Patients With Ocular Toxoplasmosis

    Completed
    • Ocular Toxoplasmosis
    • Spectral optical coherence tomography
    • (no location specified)
    Jan 22, 2020

    Neovascular Age-Related Macular Degeneration Trial in United States (hI-con1™ 60µl, hI-con1™ 150µl, hI-con1™ 300µl)

    Completed
    Has Results
    • Neovascular Age-Related Macular Degeneration
    • hI-con1™ 60µl
    • +2 more
    • Missoula, Montana
    • +4 more
    Oct 15, 2020

    Age-Related Macular Degeneration Trial in Worldwide (SB11 (Proposed ranibizumab biosimilar), Lucentis (ranibizumab))

    Completed
    Has Results
    • Age-Related Macular Degeneration
    • SB11 (Proposed ranibizumab biosimilar)
    • Lucentis (ranibizumab)
    • Poway, California
    • +74 more
    Apr 29, 2021

    Chemical Injuries, Unspecified Complication of Corneal Transplant, Autoimmune Diseases Trial in Boston (Riboflavin)

    Completed
    Has Results
    • Chemical Injuries
    • +7 more
    • Boston, Massachusetts
      Massachusetts Eye and Ear Infirmary
    Oct 18, 2019

    X-Linked Retinitis Pigmentosa Trial in United Kingdom, United States (BIIB112)

    Completed
    • X-Linked Retinitis Pigmentosa
    • BIIB112
    • Gainesville, Florida
    • +7 more
    Nov 17, 2021

    Neovascular Age-Related Macular Degeneration Trial in United States (Drug: GB-102, Aflibercept)

    Completed
    Has Results
    • Neovascular Age-Related Macular Degeneration
    • Gilbert, Arizona
    • +32 more
    Jan 10, 2022

    Neovascular Age-Related Macular Degeneration Trial in Australia, United States (Pegcetacoplan)

    Completed
    Has Results
    • Neovascular Age-Related Macular Degeneration
    • Beverly Hills, California
    • +3 more
    Sep 11, 2020

    Lymphoma Trial in Worldwide (Daratumumab)

    Completed
    Has Results
    • Lymphoma
    • Beijing, China
    • +16 more
    Dec 18, 2020

    Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

    Completed
    Has Results
    • Posterior Uveitis
    • +2 more
    • Sham Injection
    • FAI Insert
    • Hyderabad, Andhra Pradesh, India
    • +14 more
    Jul 10, 2020

    Macular Degeneration Trial in United States (Abicipar pegol)

    Completed
    Has Results
    • Macular Degeneration
    • Abicipar pegol
    • Phoenix, Arizona
    • +36 more
    Jul 17, 2020

    Retinitis Pigmentosa, Cystoid Macular Edema Trial in Ankara (SL-MPL treatment protocol was performed with a 577 nm yellow laser

    Completed
    • Retinitis Pigmentosa
    • Cystoid Macular Edema
    • SL-MPL treatment protocol was performed with a 577 nm yellow laser (EasyRet, Quantel Medical, Cedex, France)
    • Ankara, Türkiye, Turkey
    • +1 more
    Jan 21, 2020

    Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal

    Completed
    Has Results
    • Neovascular Age-Related Macular Degeneration
    • PDS Implant filled with 100 mg/mL Ranibizumab
    • Intravitreal Injections of 10 mg/mL Ranibizumab
    • Mesa, Arizona
    • +76 more
    Feb 28, 2022